Free Delivery Over $100
|
|
|||
|
||||
OverviewCompletely updated and revised, the second edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents. This simple, systematic approach defines discrete levels of psychotropics and spells out group-specific roles and responsibilities in accord with AAP policies. Plus, an included digital tool offers instant access to authoritative answers on specific conditions and medications. Topics include Conceptual framework for prescribing psychotropic drugs Medications for specific diagnoses: ADHD, Anxiety, and Depression US Food and Drug Administration-Approved antipsychotics and mood stabilizers and all other medications What to do when treatment is unsuccessful Full Product DetailsAuthor: Mark A Riddle , Rebecca A. Baum , Susan dosReis , Jane Meschan FoyPublisher: American Academy of Pediatrics Imprint: American Academy of Pediatrics Edition: 2nd Revised edition ISBN: 9781610021999ISBN 10: 1610021991 Pages: 248 Publication Date: 30 November 2018 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsIntroduction Part 1—Conceptual Framework Chapter 1—Conceptual Framework for Prescribing Psychotropic Part 2—Practical Guidance Chapter 2—Assessment Chapter 3—Prescribing Medications: Getting Started Part 3—Group 1 Medications for Specific Diagnoses: ADHD, Anxiety, and Depression Chapter 4—Group 1 Medications for Attention-Deficit/Hyperactivity Disorder Chapter 5—Group 1 Medications for Anxiety and Depression Part 4—Group 2 (FDA-Approved Antipsychotics and Mood Stabilizers) and Group 3 (All Other) Medications Chapter 6—Group 2 Medications: Antipsychotics and Mood Stabilizer Chapter 7—Group 3 Medications Part 5—Advanced Topics Chapter 8—What to Do When Treatment Is Not Successful Appendixes IndexReviews5-Star Review This is an excellent resource and I am confident primary care clinicians will find it incredibly helpful in their practice. This edition contains updated guidelines and prescribing regulations and provides online access to additional resources and information. Maria Alcocer Alkureishi, MD University of Chicago Pritzker School of Medicine Doody's Book ReviewTM This is a useful reference for medications and therapies that help pediatric patients. The book provides important messages about assessment, prescribing, and when and how to refer. Sam Kohn, MD, FAAP Asheville Children's Medical Center, NC Journal of the American Academy of Child & Adolescent Psychiatry, Volume 57, Number 8, August 2018. 5-Star Review This is an excellent resource and I am confident primary care clinicians will find it incredibly helpful in their practice. This edition contains updated guidelines and prescribing regulations and provides online access to additional resources and information. Maria Alcocer Alkureishi, MD University of Chicago Pritzker School of Medicine Doody's Book ReviewTM This is a useful reference for medications and therapies that help pediatric patients. The book provides important messages about assessment, prescribing, and when and how to refer. Sam Kohn, MD, FAAP Asheville Children's Medical Center, NC Journal of the American Academy of Child & Adolescent Psychiatry, Volume 57, Number 8, August 2018. This is a useful reference for medications and therapies that help pediatric patients. The book provides important messages about assessment, prescribing, and when and how to refer. If you provide consultative services, or regularly update your primary care colleagues, thank you! Consider suggesting this small textbook to them. And if you don't, and would like to, call around to some offices, and tell them you would like to bring by a small gift from the AAP. And then call them back in a few weeks to see if anyone has any lingering questions about your shared patients. Sam Kohn, MD, FAAP Asheville Children's Medical Center, NC Journal of the American Academy of Child & Adolescent Psychiatry, Volume 57, Number 8, August 2018. Author InformationMark A. Riddle, M.D. is Professor of Psychiatry and Pediatrics and former Director of the Division of Child and Adolescent Psychiatry at the Johns Hopkins University School of Medicine. His research, teaching and clinical practice focuses on pediatric psychopharmacology, particularly the efficacy and safety of psychotropic medications in children and adolescents. Dr. Riddle serves as a member of the National Institute of Child Health and Human Development-sponsored Data and Safety Monitoring Board for the Best Pharmaceuticals for Children Act. His clinical research and publications include pivotal studies of all of the major groups of medications prescribed to treat psychiatric disorders in children and adolescents. Jane Meschan Foy, MD, FAAP, has spent more than 35 years in pediatric primary care, public health, administration, and medical teaching. Her special interests include mental health services in pediatric primary care and school settings, access to health care for underserved populations, primary care of children with special health care needs, and residency training in mental health, community pediatrics, and advocacy. Dr Foy received her bachelor of arts from Wellesley College and her doctorate of medicine from University of North Carolina at Chapel Hill School of Medicine. She completed her residency training in pediatrics at University of North Carolina hospitals. She has held several academic positions and is currently professor of pediatrics at Wake Forest University School of Medicine and medical director of the Northwest Community Care Network (a regional network of North Carolina Medicaid providers). She is active in the American Academy of Pediatrics (AAP), having served as chair of the AAP Task Force on Mental Health from 2004 to 2010 and currently serving as past chair of the AAP National Committee on Psychosocial Aspects of Child and Family Health; member of the AAP Mental Health Leadership Work Group, and member of the AAP Board of Directors. Roles in other organizations have included the presidency of the North Carolina Pediatric Society (North Carolina Chapter of the AAP) from 1998 to 2000 and cofounder and director of the School Health Alliance for Forsyth County from 1999 to 2011. Tab Content 6Author Website:Countries AvailableAll regions |
||||
